Skip to content

Author

Chun-Hsin Wu

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Age-stratified risk of major adverse cardiovascular events with JAK inhibitors in rheumatoid arthritis: A nationwide cohort study.

BACKGROUND The cardiovascular safety of Janus kinase inhibitors (JAKi) compared with biological disease-modifying antirheumatic drugs (bDMARDs) and conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) in rheumatoid arthritis (RA) remains debated. We aimed to evaluate the risk of major adverse cardiov...

Chun-Hsin Wu, Chia-Tse Weng, Sheng-Hsiang Lin · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.